Aimei Health Technology today registered to offer 5 million units at $10 each. A unit consists of one share, one right to receive one-tenth of a share, and a warrant.
The new SPAC said it will focus on small-cap cpompanies engaged in healthcare tech and innovation, excludin any business in China, Hong Kong or Macau.
CEO and Director Juan Fernandez most recently served as general manager of Chassis Brakes International Spain, part of Hitachi automotive Systems, from April 2019 to February 2021 and was based in San Felices de Buelna, Autonomía de Cantabria, Spain. Fernandez is COO of another SPAC, Genesis Unicorn Capital, which completed its $75 million ipo in February 2022.
Spartan Capital Securities is sole bookrunning manager.
The SPAc intends to apply for a nasdaq listing, trading under AFJKU. Read more.
Source: Aimei Health Technology Files for M IPO